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Abstract
Surgical bleeding is a significant complication of surgery. Achieving homeostasis is key
to maintaining perfusion and oxygenation to vital organs. Blood product transfusion is part of the
management of surgical bleeding; however, if the underlying cause is not addressed, bleeding
can reoccur or become worse. Thromboelastography (TEG) is a non-invasive, point-of-care test
that measures the ability of whole blood to form a clot. TEG-guided blood product transfusion
has shown promising results in cardiac, obstetric, and trauma surgery as well as in patients with
cirrhosis. TEG-guided transfusion strategy can provide a more accurate and precise method to
reflect coagulopathy leading to significantly lower use of blood products when compared to
standard practice. Although TEG is key to the management of surgical bleeding, there is a gap in
its utilization in clinical practice which could be associated with a lack of clinicians’ knowledge
and competency of TEG. This quality improvement project aimed to improve clinicians’
knowledge of TEG interpretation and promote the application of TEG in clinical practice.

Introduction/Problem Statement/Significance
Problem identification
Perioperative bleeding is a significant problem nationwide leading to increased patient
morbidity and mortality rates 1(p3). Blood product transfusion therapy is not a benign
management, there are risk associated with it such as bloodborne infections, dilution
coagulopathy, citrate toxicity, and transfusion related acute lung injury.3 Empiric blood
transfusion has contributed to the blood product shortage nationwide. In 2015, 11.3 million
packed red blood cell (PRBC) units were transfused, 2.1 million platelet, and 3.6 million plasmas
2

. The average cost for blood is $ 204 for (PRBC), $ 524 for platelet, and $ 52 for fresh frozen

plasma3. It was found that the costs for acquisition, screening, and transfusion augmented
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exponentially over the past 5 years and that blood shortage is a significant problem nationwide.3
In cardiac surgery, bleeding occurs in nearly 7% of cases 4. In trauma patients, uncontrolled
bleeding is the reason for 30%-40% of all trauma-related deaths 4(p10). Patients undergoing
surgical procedures with expected significant blood loss would benefit from a precise assessment
of the hematologic system to deliver optimum care while providing cost-effective replacement of
only the needed blood components. Hemorrhage is an essential topic to the field of anesthesia
because Certified Registered Nurses Anesthetists (CRNA) are responsible for managing the
patient's hemodynamic parameters during surgical procedures. Thromboelastography (TEG) is a
promising diagnostic tool to assess coagulation deficiencies and guide clinicians to manage
bleeding during surgery with the appropriate blood product. Although (TEG) is highly valuable
to guide patient therapy, (TEG) is currently underutilized at many hospitals due to a lack of
knowledge of interpretation and techniques 5. Furthermore, there is a need for standardization
and extensive clinical studies about (TEG) 5. It is crucial to enhance the knowledge of (TEG)
among clinicians. This project aims to expand the knowledge of anesthesia clinicians about
(TEG) as a diagnostic instrument for the management of intraoperative bleeding.

Background
Hemostasis is critical to control bleeding and prevent blood loss. A balance between procoagulation factors, anticoagulants, and fibrinolysis is necessary to maintain adequate
homeostasis1(p22). The intrinsic and extrinsic pathways are the main pathways involved in the
coagulation cascade 1(p22). The extrinsic pathway is triggered through tissue factors released by
endothelial cells after an outside injury, while the intrinsic pathway is initiated through exposed
endothelial collagen1(p22). The intrinsic pathway is faster than the extrinsic pathway to achieve
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homeostasis1 (p22). Homeostasis is achieved when a platelet plug is formed and reinforced with
fibrin threads that act as bond 1 (p22).
Surgeries associated with the highest risk for disturbance in homeostasis include vascular,
cardiothoracic, trauma, liver, and obstetrics1 (p23). Multiples factors contribute to bleeding, such
as trauma, acquired congenital coagulopathies, hemodilution, hypothermia, and activation of
inflammatory pathways 1(p22). Unresolved bleeding can lead to consumption of clotting factors
and acidosis, which further exacerbates the clotting cascade and worsens the problem by creating
a vicious cycle 1(p22). Some hemostatic agents used to treat bleeding include aprotinin, tranexamic
acid, and desmopressin 1(p22). The transfusion of red blood cells, platelets, fresh frozen plasma,
and cryoprecipitate are used to restore the blood components lost during hemorrhage. The
effective management of coagulopathies during surgery will allow the surgeon to visualize the
anatomy and repair the source of bleeding. Anesthesia clinicians are responsible for maintaining
the patients’ hemodynamic parameters during surgical bleeding (TEG) can provide clinicians
with valuable information about the hematologic system and any deficiencies that need to be
replaced.

Scope of the problem
The scope of the problem is poor management of surgical bleeding and lack utilization of
TEG as a guide for blood product transfusion. Bleeding can be managed successfully through
early assessment and diagnosis. Inadequate provider competence about (TEG) contributes to the
significant problem of uncontrolled bleeding during surgery. According to the World Health
Organization (WHO), injuries associated with bleeding are responsible for about 30% to 40% of
deaths worldwide 6(p22). In a sample of 25,000 patients, a sizable proportion of patients had
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uncontrolled surgical bleeding despite current hemostat use, with rates ranging from 32% to 68%
6(p25)

. Furthermore, healthcare resource utilization, including Intensive Care Unit (ICU) stay,

ventilator use, length of hospital stays, operation time, and reoperation, were often greater in
patients with uncontrolled bleeding 6(p22). These findings revealed that healthcare cost is higher
when bleeding is uncontrolled during surgery6 (p22).
Additionally, the type of surgery plays a significant role in the risk of bleeding. Cardiac
surgeries are associated with a high incidence of bleeding due to the proximity to large vessels
such as the aorta 6(p23). During cardiopulmonary bypass, hemodilution and loss of clotting factors
can occur because of heparin administration 1(p22). For example, a prolonged time during
cardiopulmonary bypass can produce consumptive coagulopathy 1(p22). Numerous congenital
disorders associated with a coagulation factor insufficiency, such as hemophilia A or B, Von
Willebrand disease, may worsen bleeding even with minor injuries or surgeries6. Furthermore,
prescribed antiplatelet medications and anticoagulants increase the risk for coagulopathies,
leading to excessive hemorrhage associated with trauma or medical procedures 7 (p22). Therefore,
the anesthesia provider must perform a careful hematologic assessment to identify patients at risk
for surgical bleeding and take precautions to decrease the incidence for blood loss.

Consequences of the problem
Some of the consequences associated with uncontrolled perioperative bleeding and blood
product transfusion are increased patient morbidity and mortality. The lack of provider
competency of (TEG) utilization can have negative patient outcomes. For example, inadequate
provider assessment of the hematologic system or failure to recognize patient risk factors for
bleeding might lead to uncontrolled bleeding, empiric blood products administration, and
increased patient exposure to blood pathogens. There are major risks associated with blood
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products transfusion, including infections such as hepatitis B, C, Human Immunodeficiency
Virus (HIV), ABO incompatibility and transfusion-related acute lung injury 8. In addition,
platelet transfusions were associated with stroke and death during cardiopulmonary bypass in
cardiothoracic surgery 8(p22). The administration of antifibrinolytic agents used to prevent
bleeding carry risk factors as well. For example, high doses of tranexamic acid are associated
with an increased risk of postoperative seizures 8(p23). Furthermore, conservation of blood product
use is expected to come at significant cost savings of $5,000 per patient savings 6(p22). If a
solution is not found to this problem, patients would receive inappropriate treatment for bleeding
and have an increased risk of complications associated with blood product transfusions and
uncontrolled bleeding. Without utilizing (TEG), patients might receive excessive blood products
that do not target the specific coagulation problem that is causing the bleeding.

Knowledge Gap
While the National Institute for Health and Care Excellence recommends (TEG) as a tool
for hemostatic management during surgery, it is not yet the standard of clinical guidelines due to
a lack of high-quality research and awareness about the technique, interpretation, and
implications 8(p23). There is a knowledge deficit among clinicians about utilizing (TEG) in
clinical practice 8(p23). Clinicians must understand the (TEG) value results to diagnose
coagulopathies that might arise during surgery. Researchers acknowledge a lack of evidence of
(TEG) to detect Von Willebrand disease despite it being the most predominant congenital
hemostatic disorder 10. Furthermore, researchers discussed a lack of awareness about the poor
correlation between (TEG) and INR in patients taking Warfarin 5(p22). Also, there is insufficient
data to compare the exactitude of (TEG) against PT/INR in trauma-induced coagulopathies10.
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Additionally, the existing evidence of (TEG) does not measure the effect of antiplatelet therapy;
therefore, future research is needed on this topic7(p11). Moreover, there is limited research on
platelet mapping with (TEG), and it must be evaluated to improve patient care and appropriate
laboratory utilization 5(p11).
(TEG) is a point of care test that can guide the anesthesia provider to treat numerous
coagulopathies that occur during surgery. (TEG) provides a global assessment of the dynamics of
clot development, maintenance, and termination7(p10). With the utilization of (TEG), a hemostatic
assessment can be done from the initial platelet-fibrin interaction through platelet aggregation,
clot strengthening, fibrin cross-linkage, and eventually clot lysis7(p11).
The results reveal a graph tracing, and corresponding values allow clinicians to determine
the specific blood component required to treat coagulopathies8(p10). The (R) parameter represents
the reactive time from the blood placed in the machine until the initial fibrin development 9. (K)
means the clots' formation time from the beginning until stable strength is achieved 9(p22). Angle
measures the speed of clot strengthening. Maximum amplitude measures the ultimate strength of
the clot 9 (p19). Finally, the LY30 parameter measures clot lysis 9(p19). When the reactive time (R)
parameter is prolonged, administration of fresh frozen plasma may be warranted 9(p19). A
prolongation in clotting time (K) would indicate a lack of fibrinogen9 (p20). A decrease in the
angle parameter suggests a lack of fibrinogen or cryoprecipitate 9(p20). A decreased in maximum
amplitude necessitates the administration of platelets 9(p20). On the other hand, an increase in
LY30 indicates rapid fibrinolysis, which will warrant an antifibrinolytic agent 9(p20).
Several researchers have demonstrated the benefits of (TEG) to diagnose and manage
deficiencies in coagulation factors and decreased the need for unnecessary transfusion of blood
products. Furthermore, (TEG) can help distinguish from surgical and coagulopathic bleeding
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6(p22)

. Additionally, (TEG) can help determine primary from secondary fibrinolysis 6(p22). Also,

platelet functions can be assessed through (TEG) 6(p22). Therefore, to close the knowledge gap, an
intervention must be made to increase provider education about the technique, considerations,
and benefits of (TEG) on patient outcomes.

Proposal solution
The implementation of an educational module for clinicians would increase awareness
about the technique, implications, and benefits of (TEG). Learning is a continuous process that
promotes knowledge growth and development. The delivery of high-quality continuing
education to healthcare professionals stimulates excellence in healthcare performance. The
primary goal of the proposed solution is to prevent and manage bleeding complications
effectively through the utilization of (TEG). (TEG) can help identify risk factors for bleeding,
which is essential to diminish patient morbidity, mortality and improve patient outcomes. The
standardization of (TEG) in clinical practice can decrease healthcare costs by reducing excessive
blood product transfusions. Reducing unnecessary transfusions would decrease complications
associated with blood transfusions such as anaphylactic shock, infections, and transfusion-related
acute lung injury. Expanding provider understanding about (TEG) might motivate healthcare
providers to conduct future research about (TEG) utilization in other areas such as the Intensive
Care Units. An educational module nationwide would promote the application of (TEG) in
clinical practice guidelines and evidence-based practice.
In conclusion, blood loss is a major complication of surgery nationwide. Effective
measures are necessary to manage hemostasis during surgery. Blood component transfusion is
the mainstay treatment for bleeding. However, it is crucial to choose the specific blood product
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needed to achieve optimum patient outcomes. (TEG) is a promising tool that measures all the
phases of the coagulation cascade. (TEG) can assist clinicians in identifying the exact blood
product necessary to maintain homeostasis. Furthermore, the application of (TEG) can
distinguish surgical versus coagulopathic bleeding. However, there is a knowledge gap among
clinicians, limiting the applications of TEG in clinician practice. Surgical bleeding is a
significant problem that must be addressed. The implementation of an educational module as part
of a QI project can assist in closing the knowledge gap while supporting evidence-based practice
and improving patient outcomes.

Methodology of literature review
An extensive literature review was done utilizing CINAHL, Pub med, and MEDLINE
databases. The search criteria included recent research studies within the past five years to ensure
current data. The goal was to find studies that evaluate the utilization of (TEG) in clinical
practice. Furthermore, this project aims to find any knowledge gaps of (TEG). Keyword used in
the search includes thromboelastographic, cardiac surgery, cirrhosis patients, obstetric
hemorrhage, anticoagulation therapy, deep vein thrombosis (DVT), trauma, antifibrinolytics, and
orthopedic surgery. Boolean phrases used were “TEG and cardiac surgery, TEG and cirrhosis,
TEG and obstetric hemorrhage, TEG and trauma, TEG and DVT, TEG and antifibrinolytics”.
Exclusion criteria included the studies older than seven years, pediatric patients, neonates,
narrative reviews, expert opinions, and case studies. A total of 15 articles were found, however
only 8 were randomized controlled trials and were selected for the study. After a careful analysis
of the literature findings, six research studies were identified that investigate the application of
(TEG) in clinical practice. The six articles selected were randomized controlled trials to ensure
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the highest level of evidence. The search terms used included (TEG), surgical bleeding,
clinicians' knowledge, patient outcomes, and nurse anesthesia.

Introduction
Surgical bleeding is defined as a site of bleeding that is limited exclusively to the
operative site1. Perioperative bleeding is a significant complication of surgery that leads to
increased patient morbidity and mortality rates. 11(p3) In 2015, 11.3 million packed red blood cell
(PRBC) units were transfused, 2.1 million platelet, and 3.6 million plasma. 12 The average cost
for blood is $ 204 for (PRBC), $ 524 for platelet, and $ 52 for fresh frozen plasma.13 It was
found that the prices for acquisition, screening, and transfusion augmented exponentially over
the past five years and that blood shortage is a significant problem nationwide.13 It is evident
that blood product transfusion is costly, and measures must be taken to reduce unnecessary blood
component transfusion. The type of surgery and patient factors predisposing factors to surgical
bleeding and blood product transfusion. Some procedures associated with a high risk of bleeding
include cardiac, trauma, neuraxial anesthesia, obstetrics. Other patient factors that increase the
risk of bleeding are liver disease and pregnancy. Venous thromboembolism can result from
venous stasis secondary to immobilization and disruption of homeostasis during surgery. TEG is
a valuable assessment tool because it measures all stages of the coagulation cascade from clot
formation to clot lysis. TEG can guide transfusion therapy for high-risk surgeries such as cardiac
and trauma to determine the specific blood product needed with the goal of decreasing
unnecessary blood transfusion.
Additionally, TEG could assist clinicians in diagnosing hypercoagulable state after
surgery and direct effective dose for anticoagulation therapy. Homeostasis is an essential topic to
the field of anesthesia because Certified Registered Nurses Anesthetists (CRNA) are responsible
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for managing the patient's hemodynamic parameters during surgical procedures. Thus,
Thromboelastographic (TEG) is a promising diagnostic tool to assess the clotting cascade and
choose the specific blood product to manage and prevent bleeding during surgery and treat blood
clotting disorders.

Rationale
Although (TEG) is highly valuable to guide patient therapy, (TEG) is currently
underutilized at many hospitals due to a lack of knowledge of interpretation and techniques. 15
Furthermore, there is a need for standardization and extensive clinical studies about (TEG).15
Therefore, it is crucial to enhance the knowledge of (TEG) among clinicians. This project aims
to expand the knowledge of anesthesia clinicians about (TEG) as a diagnostic instrument for the
management of intraoperative bleeding.

Literature review results
TEG utilization in cardiac surgery
Cardiac surgeries are associated with a high incidence of bleeding due to the proximity to
large vessels such as the aorta.2 In addition, during cardiopulmonary bypass, hemodilution and
loss of clotting factors can occur due to heparin administration.11(p22) Therefore, careful
consideration must be taken to reduce the incidence of bleeding associated with cardiac surgery.
A randomized controlled trial evaluated the operation of (TEG) to guide blood component
therapy after cardiac surgery. This randomized controlled trial aims to determine the
effectiveness of TEG-guided blood component treatment for patients undergoing cardiac
surgery. Cardiac surgery accounts for 20% of all national blood products utilization
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nationwide.13 Therefore, clinicians must select the appropriate blood product to prevent blood
shortage nationwide while improving patient outcomes. Haensig at al13; found that a structured
protocol that includes (TEG) has been proven to be more beneficial than the empiric treatment of
surgical bleeding.13 (p1)
The study methods consisted of 104 patients scheduled for cardiac surgery. Patients were
randomly assigned to a control group and an experimental group.13 (p2) The patients in the control
group were treated based on standards coagulation testing, while the experimental group was
treated using (TEG) blood component protocol.13(p2) Primary outcomes were transfusion
requirements of red blood cells, platelets, plasma, fibrinogen, or clotting factors. The secondary
results were 24 hours drainage loss, re-thoracotomy rate, and cost analysis of blood and
coagulation products. To maintain consistency and improve accuracy in the study, all patients
receive the same intraoperative care and management in the intensive care unit.13(p2) A power
analysis was conducted and revealed that 30 patients per group would be needed to prove a 40%
reduction in the use of allogeneic blood products.13(p2) The statistical analysis was performed
using the software SPSS, version 24. Continuous variables are expressed as mean, standard
deviation.13(p2) The authors utilized the two-tailed Student's t-test and the Mann-Whitney U-test
to compare continuous variables.13(p2) Furthermore, a p-value of less than 0.05 was deemed
statistically significant. 13(p2) The clinicians performing the data analysis and statistical
calculations were blinded to prevent biases analysis.13(p2) The authors found less bleeding within
the first 24 hours in the (TEG) group when compared to the control group.13(p5) However, within
30 days, (2%) in the TEG group and (6%) in the control group suffered a stroke.13(p6) These
findings might suggest that the use of unnecessary blood components might be associated with
an increased risk of stroke.
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Furthermore, the mortality rate was 8% in the control group, while the mortality rate in
the (TEG) group was 2%.13 (p5) In addition, at five years, there was a mortality rate of 12% in
control and 4% in the (TEG) group. 13 (p5) These findings suggest that TEG is associated with
better survival rates after cardiac surgery, lower patient mortality rate, and enhanced outcomes.
Patients in the (TEG) group received fewer platelets concentrates and aprotinin, while the control
patients needed less fibrinogen. 13 (p5) In addition, the investigators found that the (TEG)
experimental group experienced substantially less blood loss within the first 24 hours. 13 (p5)
These findings are significant because blood loss is associated with significant impairments to
the homeostatic system and higher rates for re-thoracotomy. The study findings revealed cost
savings because there was a decrease in unnecessary blood products; however, there was an
additional cost for (TEG) testing. 13 (p5)
Some study limitations included a small cohort of study participants and a lack of
homogeneity. 13(p5) Furthermore, there was limited evidence about the structure of the TEG
algorithm, and platelet response was not evaluated in the study. 13 (p5) The authors demonstrated
not only a decrease in mortality with TEG-guided transfusion therapy but also revealed the risks
associated with unnecessary blood transfusion products. The authors included some secondary
sources to support their research study. The study is well-organized with an introduction,
background, methodology, discussion, and conclusion. One limitation is that the hypothesis was
not stated directly, but it was implied throughout the study. This research study supports the
effectiveness of TEG to decrease unnecessary blood product transfusion and improve patient
outcomes in cardiac surgery.
TEG to direct transfusion therapy in patients with cirrhosis
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While Haensig et al 12 and colleagues focused on examining the application of TEG in
cardiac surgery, Kumar et al
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focus on the utilization of (TEG) in a patient with cirrhosis

undergoing surgeries. Homeostasis is directly correlated to liver function because the liver
synthesizes many coagulation factors. Therefore, patients with cirrhosis do not have vitamin-Kdependent coagulation factors such as II, VII, IX, and X, which increase the risk for surgical
bleeding.14 (p10) Therefore, TEG is a valuable tool for this patient population due to their
abnormal coagulopathies, which places them at a higher risk for bleeding during surgery. Kumar
et al 14 and colleagues aim to assess the effectiveness of (TEG) in patients to diagnose
coagulopathies in patients with liver impairment. 13 (p10) The study consists of 100 patients who
underwent percutaneous liver biopsy, trans jugular intrahepatic portosystemic shunt, and trans
arterial chemoembolization. 13 (p10)
A computer randomly assigned patients to the control or (TEG) experimental groups in a
1:1 ratio. 13 (p10) The participants, investigator, data analysts, and clinician were blinded to
improve accuracy and prevent biases. 13 (p10) The data findings were managed using the software
package SPSS version 20.0. 13 (p10) The chi-square and Fisher's exact tests were utilized to
establish a relationship. 13(p10) To compare continuous variables, the student t-test and MannWhitney U test were used. 13(p10) It was also noted that the P values were two-sided. A P value of
less than 0.05 was considered significant. 14 (p10) This study found that the blood component
utilization was lower when using TEG to guide transfusion therapy. 13 (p10) In the (TEG) group,
only 26.5 % of patients were transfused with all types of blood components versus 87 % in the
control group. 13(p10)
Furthermore, it was discovered that TEG-guided transfusion reduces transfusion of FFP
in patients undergoing liver transplantation, although it does not affect the 3-year survival rate. 13
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(p10)

Subsequently, the transfusion-related reaction was less in the TEG group than in the control

group. 13 (p10) Additionally, TEG is superior to the International Normalized Ratio (INR) or
platelet count to estimate the risk for bleeding. 13(p10) Transfusion-related acute lung injury
(TRALI) is a significant complication of blood transfusion. 13(p10) The authors found that patients
with end-stage liver disease who received transfusion therapy developed (TRALI) more
frequently than those without it. 13 (p10) Therefore, it is crucial to prevent unnecessary blood
product transfusion in this patient population with liver disease because they are at higher risk
for transfusion-related reactions and complications. Additionally, more units of fresh frozen
plasma were transfused using an (INR) of greater than 1.8 compared with the TEG R time of
greater than 10 minutes. 13(p10) Similarly, more platelets were transfused using standard platelet
counts than with TEG MA less than 55 mm. 13(p10)
One of the study weaknesses is that the coagulation levels were not measured during
blood component transfusion to compare the findings and effectiveness of therapy. 13 (p10) The
study objective was clearly defined. The background, methodology, discussion, and conclusion
were appropriate. Research findings were presented in a graph and discussion to compare the
results. This study demonstrates the usefulness of TEG on patients with cirrhosis undergoing
surgical procedures. Both Haensig et al 13 and Kumar et al 14 have similar sample sizes, and study
participants were randomly selected, demonstrating comparable and accurate findings.
Furthermore, both researchers discovered that TEG utilization improves patient outcomes while
reducing blood products requirements during surgery. Both clinicians used SPSS software for
statistical analysis, and a P value less than 0.005 was considered significant in these two studies.
TEG to guide transfusion therapy in obstetric hemorrhage
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Haensig et al 13 evaluated the efficacy of TEG in cardiac surgery, while Kumar et al 14
assessed the application of TEG in patients with cirrhosis. Similarly, Karlsson et al 14 evaluate
the application of TEG in obstetric hemorrhage.14 Obstetric is associated with a high incidence of
surgical bleeding due to coagulation disorders related to pregnancy, uterine atony, abnormal
placenta placement, and retained placenta.14(p13) Subsequent disseminated intravascular
coagulopathy (DIC) can occur, leading to consumption of clotting factors and further bleeding.
14(p13)

The objective of this study was to compare the efficacy of TEG with standard laboratory

analysis to predict and manage bleeding. 14(p13) Postpartum hemorrhage is the cause of 73% of all
morbidity during pregnancy, and it is a common cause of intensive care admission in pregnant
patients. 14(p13) The study participants consisted of forty-five women with major obstetric
hemorrhage and 49 women with blood loss <600 mL.14(p13) The parameters measured were
(TEG-R), (TEG-K), (TEG-Angle), (TEG-MA), and (TEG-LY30) to compare with a standard
parameter such as prothrombin time, fibrinogen, antithrombin, and d-dimer. 14(p13) Results are
presented as mean, standard deviation, and 95% confidence interval. 14(p13) Pearson's correlation
assessed the relationship between estimated blood loss, TEG variables, and hemostatic
laboratory analysis. 14(p13) A correlation coefficient > 0.5 and a P value less than 0.01 were found
to be significant. 14(p13) All data and statistical analysis were performed in SPSS version 19. 14(p13)
The study clinicians found that homeostasis is impaired with major obstetric hemorrhage.
5(p13)

TEG is a valuable tool because it provides rapid and clinically significant information about

hemostatic variations in obstetric hemorrhage. 14(p13) Furthermore, TEG can assist clinicians in
detecting coagulation deficiencies to determine the specific blood product therapy at an earlier
point than traditional laboratory testing. 14(p13) TEG showed faster initiation of blood clotting,
less ﬁbrin clot strength, and depressed ﬁbrinolysis during major obstetric hemorrhage than
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normal delivery.14(p13) Furthermore, TEG-LY30 was 75% lower in women with major obstetric
hemorrhage, indicating impaired clot formation. 14(p13)
The authors clearly stated the objectives of the study along with some background
information to identify the problem. No research question was clearly stated, but it was implied
during the study. One study's limitations are that there was no standardized transfusion strategy
or consistent methods for transfusion and fluid management, which might have distorted the
study outcomes. 14(p13) Another study discrepancy is that some women were given tranexamic
acid while others were given plasma to manage bleeding. 14(p13) Finally, there was no analysis of
hematocrit or capillary hemoglobin. 14(p13) A final limitation is a possible inaccuracy of estimated
blood loss (EBL). 14(p13) Nevertheless, the study validates the feasibility of TEG in major
obstetric. TEG is a point of care laboratory that can provide accurate and fast results during
obstetric hemorrhage.
Haensig et al 13, Kumar et al 14 and Karlsson et al14 had approximately 100 participants in
the studies, indicating accurate mean values. Kumar et al 13 and Karlsson et al 14 and Haensig et
al 13 established a comparison between TEG guided therapy versus stand coagulation laboratory
results. Haensig et al 12 and Kumar et al 13 deemed significant a P value less than 0.05 while
Karlsson et al 15 considered a P value less than 0.01 to be substantial, indicating substantial
evidence against the null hypothesis. The previously mentioned studies were randomized
controlled trials with around 100 study participants, ensuring the accuracy of study findings.
Furthermore, the studies were conducted within the last seven years which guarantees current
data. Karlsson et al 15 conducted the study in Sweden, while Haensig et al 13 conducted it in
Germany. Studies conducted outside the United States have many implications because
European countries might follow different guidelines, standards of care, and protocols.
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TEG to guide anticoagulation therapy for thromboembolism (VTE)
Previous studies focus on the management of bleeding on cardiac and obstetric surgeries
and patients with cirrhosis undergoing invasive procedures. On the other hand, Connelly et al 15
investigate the utilization of TEG decreases the risk of venous thromboembolism. The study is
different from previous studies in that the Connelly et al 15 and colleagues test the effective dose
of anticoagulation for Venous thromboembolism prophylaxis by using TEG. Venous
thromboembolism (VTE) is a complication of surgery secondary to lack of immobilization and
homeostasis impairment, leading to increase patient morbidity and mortality. 15 Prophylactic
Enoxaparin is used to prevent venous thromboembolism (VTE) in patients at risk for (DVT).
15(p13)

Despite the utilization of Enoxaparin (DVT) is still a significant source of morbidity and

mortality after surgery due to antithrombin III or anti–Factor Xa deficiencies or missed
enoxaparin doses. 15 (p13)
This study aims to assess the efficacy of TEG to determine the exact dosing of
Enoxaparin to prevent (DVT). 15 (p13) The study compared the usual dosing of 30 mg twice daily
versus TEG-adjusted enoxaparin dosing, 35 mg twice daily for 185 surgical and trauma patients,
a larger sample size than previously discussed studies. 15 (p13) Surprisingly, the findings revealed
that patients in the experimental group who received larger dosages of Enoxaparin guided by
TEG did not have a significant difference in the incidence of (DVT). 15 (p13) The authors suggest
that missing one or more doses of Enoxaparin may offset any possible positive effects of dose
adjustment in the experimental group. 15 (p13) Additionally, the (TEG-R) parameter was
associated with increased incidence (DVT) when it was less than 1 minute. 15 (p13) The incidence
of VTE was comparable 6.7% in the experimental vs 6.3% in the control group. 15 (p13) To
demonstrate statistical significance, 3212 total patients would be desirable. 15 (p13) Therefore, a
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small number of participants was one of the study's weaknesses. Secondly, several patients in
each group missed at least of dose of the anticoagulant, which is a recognized risk factor for
DVT.
Additionally, the physiologic effects of the dose adjustment were not observed until later
in the study, which could lead to erroneous results. 15 (p13) Finally, there were inconstant
screening protocols at the participating institutions. 15 (p13) It is recognized that TEG can assist
clinicians in managing acute bleeding; however, there is limited research on how TEG can be
used to determine the effective dose of anticoagulation with Enoxaparin. When compared to
previous studies that demonstrate the efficacy of TEG in cardiac, obstetric, and patients with
cirrhosis, this study did not validate that TEG-guided anticoagulation therapy can improve
patient outcomes. However, some of the study inconsistencies might have affected the validity of
this study. Therefore, further research is necessary to address the gaps and expand knowledge of
TEG in clinical practice.
TEG to guide antifibrinolytic therapy
Whereas Connelly et al 15 focus on TEG-guided anticoagulation therapy to prevent
(VTE), Xu et al 16 evaluate the application of TEG in determining best route of administration for
antifibrinolytic therapy during hip surgery. Connelly et al 15 and Xu et al 16 focused on
medication therapies to manage bleeding and (VTE). All studies are randomized controlled trials
within the last six years which demonstrate accurate and current data. With an increased aging
population, orthopedic surgeries are becoming more common. Orthopedic procedures are
associated with a considerable amount of blood loss. 16 Among orthopedic surgeries, total hip
arthroplasty has the highest risk for bleeding, with a mean of 1,500 ml of blood loss. 16 (p14)
Therefore, intraoperative blood management during hip arthroplasty is an essential topic for
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anesthesia clinicians. To decrease blood product transfusion, Tranexamic acid (TXA) is
commonly used in orthopedic surgery. TEG is a valuable tool for orthopedic surgery to assess
the coagulation cascade and determine when antifibrinolytics are needed. For instance, an
increase in LY30 indicates rapid fibrinolysis, which will warrant an antifibrinolytic agent. 16(p14)
Some clinicians investigated the implementation of thromboelastography to assess the effect of
different administration methods of Tranexamic acid on coagulation cascade in total hip
arthroplasty. 16 (p14)
The randomized study consisted of 207 patients who had total hip arthroplasty. 16 (p14) A
computer program randomly assigned patients to three topical-TXA, IV-TXA, and control
groups. 16 (p14) The main results measured include the rate of DVT, blood loss, and transfusion
rates. 16 (p14) TEG was utilized to assess coagulation from preoperative to 7 days postoperative.
17(p14)

TEG results revealed that that intravenous injection (TXA) promotes a hypercoagulable

state. On the other hand, the group that received topical-TXA and the control group did not
increase the TEG-MA parameters. 16 (p14) These findings demonstrate that topical TXA is not as
effective as IV therapy for hip arthroplasty. 16(p14) The topical-TXA group and IV-TXA group
had less blood loss than the control group, with a P value of less than 0.05. 16 (p14) The control
group had higher blood loss because no TXA was used. 16 (p14) The IV-TXA group IV-TXA
group improved coagulation peak values (P < 0.05). 16(p14) MA values increased steadily from
preoperative levels to the seventh day postoperatively. 16(p14) Nearly no meaningful changes were
observed between topical-TXA and control groups. 16(p14) The ANOVA was used to assess
homogeneity and statistical significance between the groups. 16 (p14) The analysis of qualitative
variables was guided using Pearson's chi-square, Fisher's exact test. 16(p14) Additionally, the SPSS
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software version 19.0 was used for the statistical analysis. 16(p14) Finally, a p-value < 0.05 was
considered significant. 16(p14)
Some of the study limitations include a small sample size. 16(p14) A larger sample size is
necessary to examine the effects of (TXA) on (TEG) parameters and obtain more broad and
accurate findings. 16 (p14) Secondly, longer postoperative monitoring is needed for TEG
evaluation. 16 (p14) Third, serum concentrations of TXA were not measured to evaluate the rate of
systemic absorption of TXA. 16(p14) This study reveals the usefulness of TEG in orthopedic
surgery to guide antifibrinolytic therapy reducing blood transfusion. TEG can assist clinicians in
determining the most effective route of antifibrinolytic therapy to decrease the risk of bleeding.
TEG utilization in trauma surgery
Previous studies revealed the successful application of TEG-guided therapy in cardiac
and obstetric surgery and for an antifibrinolytic and anticoagulant effective dose. Similarly,
Gonzalez E et al 17 investigated the role of TEG in guiding blood product transfusion during
trauma-related coagulopathies. In trauma, the rapid loss of circulating blood volume can lead to
shock and death, which increases patient morbidity and mortality. 17 The acute coagulopathy
associated with trauma is a multifactorial process that occurs from an arrangement of shock,
tissue injury leading to the activation of anticoagulant and fibrinolytic pathways, and thrombin
generation. 17 (p11) The coagulations can be worsened in certain conditions such as acidemia,
dilution, hypoperfusion, and homeostasis factor consumptions. 17 (p11) This randomized controlled
trial reviews the utilization of TEG to guide hemostatic resuscitations of trauma-related
coagulopathies. 17 (p11) This investigation entails 101 participants who were injured from a level
-1 trauma hospital. 17 (p12) Patients were randomly assigned to be managed by a massive
transfusion therapy (MTT) directed by conventional coagulation assays (CCA) such as
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fibrinogen (INR) and platelet count or TEG. 17 (p12) The PASS-11 software was used to calculate
the sample size and power. 17 (p12) It must be noted that a sample of 122 patients would be
desirable to achieve 80% of power analysis and identify a 20% difference in the survival rate
between the two groups. 17 (p12) All tests were 2-tailed, and the significance was set at P<0.05.
18(p12)

The study finding revealed that the group that used TEG during massive transfusion

therapy received less plasma and platelet when compared to conventional coagulation assays.
17 (p12)

Although the control group received more platelets and plasma transfusion, this did not

improve the coagulation values in the (CCA) group. 17 (p12) These findings demonstrate that more
blood product utilization does not indeed lead to better results. 17(p12)
Additionally, the TEG-guided (MTP) patients spent fewer days on the ventilator in the
intensive care unit. 17(p12) After trauma, plasma and platelet transfusion can lead to organ
dysfunction, which can explain the TEG group's decreased number of intensive care unit (ICU)
admission and ventilator days. 17(p12) The TEG cohort had increased survival rates at 28 days and
6 hours from trauma. 17 (p12) The difference in deaths secondary to bleeding was 23.4% in the
(CCA) group compared with 7.8% in the TEG group. 17 (p11) One weakness identified is that the
study was not intended to test one coagulation assay but rather to represent a broad picture of
how clinicians deliver care. 17 (p12) The sample size was an additional weakness of this study.
17(p12)

A larger sample size would increase the power analysis and improve the accuracy of the

survey. 17 (p12) When compared to previous studies, this was a smaller sample size representation
which might affect the exactitude of the study findings.

Discussion
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The six research studies selected were randomized controlled trials which demonstrate
the highest level of evidence. The investigators effectively showed the utilization of TEG in
clinical practice. All studies were conducted within the last 6 years. Karlsson et al 15 and Haensig
et al 13 conducted their studies in Sweden and Germany, while the rest were conducted in the
United States. Research studies conducted abroad might have different regulatory and legal
systems. The study participants were randomly assigned into a controlled and experimental
group. To increase the accuracy, the clinicians were blinded during the statistical analysis. The
number of study participants was similar in all the studies except for Gonzalez E et al 18, who
had less than 200 participants.
A larger study would be ideal to obtain more reliable results with greater precision and
power. All researchers used SPSS software for the statistical analysis. A P value < 0.05 was
considered significant in most studies except for Karlsson et al 15, who deemed P-value < 0.01
substantial. All researchers used SPSS software for the statistical analysis. Thus, the research
investigator provides sufficient evidence to validate the effective use of TEG in clinical practice.
The authors had no conflict of interest in the study. Small sample size was a common limitation
in all the studies. Haensig et al 13 report that there was considerable preoperative homogeneity
regarding the incidence of von-Willebrand-Syndrome in the study. Gonzalez et al 18 conducted a
prospective study where the participants were monitored for 28 days after the trauma for survival
rate. Similarly, Haensing et al 13 monitored the patients for 30 days after cardiac surgery to assess
the survival rate after TEG-guided transfusion versus stand coagulation parameters.

Summary of literature review
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Surgical bleeding is a significant complication from surgery. (TEG) provides a global
assessment of the dynamics of clot development, maintenance, and termination. 19(p10) The
literature review has proven multiple applications of (TEG) in clinical practice in different
clinical settings. The utilization of (TEG) plays an essential role in cardiac surgery to decrease
unnecessary blood products transfusion while improving survival rate.12(p 20) Additionally, TEG
was found to be effective in guiding transfusion therapy in patients with cirrhosis.13(p1) This
patient population is at higher risk for bleeding due to the inability of the liver to make clotting
factors. Furthermore, TEG was utilized in obstetric hemorrhage and demonstrated faster results
to guide transfusion therapy.15(p10) Moreover, the application of TEG was advantageous to
determine the effective dose of Enoxaparin to reduce (DVT) incidence after surgery and trauma.
16(p12)

In addition, TEG has shown to be significant in evaluating the efficacy of different

methods of (TXA) administration in orthopedic surgery to minimize blood product
transfusion.17(p10) Finally, one of the studies proved that TEG can improve survival rate while
decreasing morbidity and mortality in trauma patients by guiding blood transfusion therapy.18(p10)
The literature review demonstrate that TEG is a valuable tool, therefore it must be incorporated
into the standard of care to improve patient outcomes and survival rates.
An educational module to improve the knowledge of Thromboelastography among clinicians

Purpose/ PICO
Clinical Questions/Objectives
Population (P): Clinicians
Intervention (I): Intervention to improve the knowledge of Thromboelastography (TEG)
Comparison (C): None
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Outcome (O): Improve clinician knowledge of Thromboelastography (TEG) to manage surgical
bleeding.
Objective: to improve provider competency of TEG in clinical practice
Definition of Terms
Thromboelastography: TEG is a non-invasive test that quantitatively measures the ability of
whole blood to form a clot. The principle of this in vitro test is to detect and quantify dynamic
changes of the viscoelastic properties of a blood sample during clotting.16 (12)
Change: change is the transformation of tasks, processes, methods, structures, and/or
relationships.19
Provider competency: Provider competence entails having and demonstrating the “knowledge,
skills, abilities, and traits” to successfully and effectively delivery high-quality services.
Competency can be built during pre-service education as well as in-service education and is not
limited to technical knowledge.20
Evidence-based practice: evidence-based practice (EBP) focuses on growing an environment
where evidence supports clinical and administrative decision-making to ensure the highest
quality of care, promotes optimal outcomes, and creates a culture of critical thinking and
accountability.19(p59)
Conceptual Underpinning and Theoretical Framework
Lippitt's model of change is an appropriate theoretical framework for this quality
improvement project. Change to current practice in necessary promotes the utilization of TEG to
guide blood component transfusion. Understanding and utilizing a theoretical framework can
assist project managers in increasing the likelihood of project success. Lippitt explores the
different stages of change within an organization.16 Lippitt, Watson, and Westley built on the
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work of Lewin's theory of organizational change.16 (p66) The seven steps of change are: 1 develop
the need for change by diagnosing the difference, 2 Establish change relationship and assess the
motivation and capacity to change, 3 clarify assessment for change and determine resources, 4
establish goals and intentions for an action plan, 5 examine alternatives, 6 transform intentions
into actual change and maintain the change, 7 generalize and stabilize change and end the
helping relationship of the change agent.16(p67) Lippitt's theory of change is similar to the nursing
process because it entails an assessment, planning, implementation, and evaluation.16(p67))

Setting and participants
The setting for this project took place in a 1,013-bed level one trauma hospital with
twenty-two operating rooms and a mixture of anesthesia providers. Providers include
anesthesiologists, certified registered nurse anesthetists (CRNA), and anesthesiologist assistants
(AA) with various experience levels. These providers perform anesthesia for multiple
procedures, including orthopedics, vascular, thoracic, and trauma. Patients receiving care in this
facility also suffer numerous comorbidities such as congestive heart failure, liver disease,
obstetric complications, coronary artery disease, diabetes mellitus, and additional risk factors.

Recruitment and Participants
Recruitment was obtained via email invitation; surveys were be done virtually. An
informational letter was sent to all anesthesia personnel in the operating room, inviting them to
participate in the project. An anonymous link to the pre-intervention survey was included in the
email. In addition, providers completed the pretest assessment survey on their mobile devices or
computers via the Qualtrics survey platform. These protective measures ensured the safety of the
data.
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All participants who met the inclusion criteria were invited to participate in this voluntary
educational module. Anesthesia providers working for other companies and hospital employees
were excluded from participating in this educational module. Potential benefits to participants
include improved knowledge of TEG, effective management of surgical bleeding, and
application of TEG in blood transfusion protocol. The potential risk of participating in this
educational module includes mild physical discomfort from sitting or standing for an extended
period.

Intervention and Procedures
Bleeding remains a common occurrence during surgery. Inadequate surgical hemostasis
can lead lactic acidosis, hypovolemic shock, disseminated intravascular coagulation and multi
organ dysfunction. In addition, empiric blood transfusion has contributed to the blood product
shortage nationwide.3 Inadequate blood product transfusion therapy is not a benign management,
there are risk associated with it such as bloodborne infections, dilution coagulopathy, citrate
toxicity, and transfusion related acute lung injury.3 Therefore, this problem must be addressed by
educating anesthesia providers. Educational intervention is critical to gathering participation and
support for utilizing thromboelastography to assess the etiology of surgical bleeding. The
academic module educated participants on TEG values interpretation, risk factors for surgical
bleeding, and the benefits of TEG application in clinical practice. A voiceover PowerPoint was
provided with the module to explain the information and data further. The educational session
included reflection questions to help learners assess their knowledge before and after the module
and consolidate the knowledge acquired from the presentation.
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An email was sent to the anesthesia providers inviting them to participate in this
education module. An anonymous link was included in the email, allowing them to access the
pretest, learning module, and post-test. The provider could complete these sections on their
mobile devices or computers via the Qualtrics survey platform. No personal identifiers were
captured, allowing for anonymity. Once the provider clicked on the given link, they were taken
directly to the learning module. First, project partakers viewed an introductory letter explaining
the procedure for participation, the voluntary nature of the project, contact information to the
principal investigator, and consent for participation. Next, they were directed to a pretest
questionnaire, followed by a voiceover presentation. Lastly, a post-test was provided.
Protection of Human Subjects
All data were collected anonymously. Institutional Review Boards (IRB) approval from
Florida International University was obtained prior to launching the project. No identifiable
private information was collected as part of the pretest and post-test surveys. Only investigators
have access to the completed pretest and post-test surveys. There are no hard copy forms. Data
collected from the pretest and post-test surveys will be tabulated anonymously to electronic
spreadsheets, which will be maintained on a password-protected laptop computer. These
measures further ensured the protection of participant identity.

Data Collection
The primary instruments utilized to collect data for this project included a 3-step process
using the Qualtrics data collection system, including a pretest survey, a video-based educational
module, and a post-test survey. The collected data will help to identify the anesthesia providers'
knowledge of TEG to manage surgical bleeding. Once the data is collected, it will be imported
into the SPSS statistics software to be analyzed.
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Measurement and Analysis
The staff knowledge of TEG was measured before and after the educational module. The
pretest and post-test included the same questions to directly assess change in knowledge on TEG
to manage surgical bleeding and the effectiveness of the learning module. Both surveys
contained eleven multiple-choice questions to evaluate clinicians' competency. The pretest
included demographic questions regarding gender, race, age, position, and years of practice. Data
collected from the Qualtrics pretest and post-test questionnaire was exported into SPSS statistics
software. This allowed for analysis of each survey and the associated responses. In addition, a
statistical analysis was conducted to determine if a change in knowledge occurred after viewing
the educational module.

Results of quality improvement
Pretest and Posttest Sample
Upon original access to Qualtrics, the preintervention survey contained 30 participants.
Of these, 30 participants, 21 did not receive a random ID number and did not answer the
demographic questions asked. Six participants who logged onto the survey could not complete
the study due to errors with the question display and random ID display. After evaluation, the
post-intervention survey was also not completed by these 21 individuals. Therefore, the
preintervention sample contained 9 participants. The participants varied in gender, race, position
held, and the number of years in anesthesia practice. Of the pre-intervention participants, female
participants dominated and only included two males. The participants' races varied, with
Caucasian individuals serving as the largest group (n = 4), followed by Black/African American
participants (n = 3). CRNAs made the largest group of participants in the educational module (n
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= 9). Years of experience also varied; most participants had between 0- 5 years of experience (n
= 7). The complete demographic breakdown of the preintervention sample is described in table 1.
Nine (n = 7) of the original 31 participants participated in the educational module and completed
the post-test survey. All seven of these participants were CRNAs (n = 7, 100%) and included 2
males (n = 2, 28.6 %) and 5 females (n = 5, 71.4 %). Age of those who completed the
postintervention varied amongst these individuals. People between the ages of 25-35 dominated
at (n = 4, 50%) followed by the 46-55 age group (n = 2, 25%). The data also represented a range
of ethnicities: Hispanic (n = 1, 11 %), Caucasian (n = 4, 44 %), Black or African American (n =
3, 33%), Asian (n = 1, 11%). The data also represented people of varying years of experience in
anesthesia practice: 0-2 years (n = 3, 37.5%), 3-5 years (n = 2, 25%), 6-10 years n = 1 12.5%),
over 10 years (n =2, 25%). Table 4 displays the post-intervention demographics.

Demographics table
Demographic items
Table 1
Pre- test demographic
N= 9

Post-test demographic
N= 9

Gender
Female: N=7
Male: N=2

Gender
Female: N=7
Male: N=2
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Race:
Hispanic : N= 1, 11%
Caucasian: N= 4 , 44%
African American: N= 3 , 33%
Asian: N=1, 11%

Race:
Hispanic : N= 1, 11%
Caucasian: N= 4 , 44%
African American: N= 3 , 33%
Asian: N=1, 11%

Education
Master’s degree: N=6
Doctorate: N=3

Education
Master’s degree: N=6
Doctorate: N=3

Years of experience:
0 -2 years, (n = 3, 37.5%)
3-5 years (n = 2, 25%), 6-10
years n = 1 12.5%), over 10
years (n =2, 25%).
Greater than 10 years: (n =2, 25%).

Years of experience:
0 -2 years, (n = 3, 37.5%)
3-5 years (n = 2, 25%), 6-10
years n = 1 12.5%), over 10
years (n =2, 25%).
Greater than 10 years: (n =2, 25%).

Pre-test knowledge
The pretest served to gather current knowledge about TEG interpretation as well as the
application and benefits of TEG in clinical practice. Nine clinicians took the pretest and posttest.
Table 2 displays the scores for subcategory 1 which measures clinicians’ competency to interpret
TEG values before the educational module. Table 2 illustrates the scores for subcategory 2 which
evaluates provider’s competency to understand TEG’s application in clinical practice. The
pretest showed the participants had limited knowledge of the interpretation of TEG and its
application in clinical practice. It also demonstrated a lack of understanding regarding the
benefits of TEG in trauma, cardiac, liver, and obstetric surgery. The participants scored the least
when questioned about interpreting TEG parameters such as K value, R parameter, Maximum
amplitude, and LY 30. Additionally, the study participants scored the least when asked about the
accuracy of INR versus TEG in predicting the risk for bleeding in patients with cirrhosis (n=2,
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35%). These findings demonstrate a deficiency in clinicians' knowledge of TEG values
interpretation which can be related to its underutilization in clinical practice. The participants
scored the highest when asked about the benefits of TEG in cardiac surgery to decrease the
number of unnecessary blood product transfusions (n=9, 100%).
Results table
Table 2
Difference in Pre-test and Pos-test
Knowledge of TEG values interpretation
Subcategory 1
Q1: Which blood product is appropriate when
the R parameter is prolonged?

Pretest

Post-test

Difference

50 %

100%

+ 50%

Q2: A prolongation in clotting time (K) would
indicate?

22%

100%

+ 78%

Q3: A decreased in maximum amplitude
necessitate the administration of which blood
product?

50%

87%

+37%

67%

90%

+23%

Q4: What does an increase in LY30 indicates?

Table 3
Difference in Pre- test and Posttest knowledge of
TEG application in clinical practice
Subcategory 2
Q5: TEG has been proven to decrease unnecessary
blood product transfusion after cardiac surgery true
or false?

Pre-test

Post-test

Difference

100%

100%

0%

Q6: Unnecessary blood product transfusion can lead
to what?

66.7 %

100%

+33.3 %

Q7: In patients with cirrhosis, TEG is superior to
international normalized ratio (INR), or platelet
count to estimate the risk for bleeding, true or
false?

87.5 %

100%

+12.5%

78%

100%

+22%

35%

70%

+35%

55%

100%

+ 45%

90%

100%

+ 10%
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Q8: Obstetric hemorrhage can lead to what?
Q 9: Patients with end-stage liver disease who
received transfusion therapy are at higher risk for?
Q10: True or false: TEG can detect coagulation
deficiencies in obstetric hemorrhage at an earlier
point compared with traditional laboratory testing?
Q11: TEG-guided transfusion protocol has shown to
improve patient survival rates in trauma true or
false?
Post-test
Table 2 and 3 displays the post-test results for the 2 main subcategories. After viewing
the narrated educational module, some areas improved while others remained stagnant. The
questions were categorized into two subgroups: subgroup 1 included questions about TEG values
interpretation, while subgroup 2 incorporated questions about TEG application in clinical
practice. There were four questions include in subcategory 1 and seven questions in subcategory
2. The average score in subcategory 1 pre-test was 48.5%, while the post-test was 94%. These
results demonstrate a level of improvement of 45.75 % in staff's understanding of TEG values. In
subcategory 2, the average score for the pre-test was 73 %, while the average score in the posttest was 95.7%. The findings demonstrate a level of improvement of 22% in clinicians'
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knowledge base of TEG application in clinical practice. Some areas showed no change between
the pre and post-test results. For instance, the participants scores did not change when asked
about the utilization of TEG in cardiac surgery (n=9, 100%). Overall, there was a significant
educational development in all subcategories after implementing a learning module. The
outcomes demonstrate that clinicians had an existing basic understanding of TEG application in
clinical practice; however, there was a greater knowledge deficiency in interpreting TEG values.
The factors identified in the study attempt to explain the underutilization of TEG in clinical
practice.

Summary of Data
Overall, a substantial change in knowledge did occur. The overall score of the pre-test
was 67%, while the overall score of the post-test was 95% which demonstrate an improvement of
28%. There was no change in scores when clinicians were asked about the efficacy of TEG
application in cardiac surgery, demonstrating an existing knowledge of TEG application in
clinical practice. Still, it should be noted that one of the questions received a 100% pass rate in
the pre-test, thus showing the participants did not change their answers. Some scores remain the
same while others increase. However, none of the scores decreased. This quality improvement
project identified knowledge gaps among anesthesia clinicians that must be addressed to increase
the utilization of TEG in clinical practice.
Discussion of quality improvement
Limitations
This survey was distributed to 50 individuals via email; however, 30 individuals started the
survey but did not finish it. Out of the total of participants who attempted the survey, only 9
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participants completed the pre-intervention and post-intervention surveys. A limitation of this
data is all the participants were CRNAs and did not represent the attitudes and knowledge of the
various anesthesia providers at this site. However, the goal of this quality improvement project
was to enhance clinician’s knowledge of TEG interpretation and clinical application and not to
make findings generalizable. The delivery method of this survey may also serve as a limitation,
as this required self-direction, and it is possible participants were unable to set a specific time to
focus on the information provided. Providing an in-person class would have ensured the
participants viewed the narrated educational module and possibly yielded more reliable data. A
total of 30 staff members started the module but did not complete it; therefore, these participants
were excluded from the results. Only 9 participants completed the pre-test and post-test and
watched the educational video, therefore these individuals were included in the data analysis.
The participants' inability to complete the module could have been related to technical
difficulties or time constraints.

Future Implications for Advanced Nursing Practice
Surgical bleeding is a complication associated with surgery. Blood product transfusion is
not a benign intervention because it carries risks for the patients. Measures to reduce the
incidence of empiric blood products must be implemented. The outcome of this study
demonstrates a need for more information on TEG interpretation and application in clinical
practice. The data collected shows that educational modules can effectively educate providers
and change their attitudes regarding TEG application. This DNP project has beneficial
implications for the advancement of nursing practice. The improvement in clinician competency
of TEG demonstrates the effectiveness of an evidence-based educational intervention.
Furthermore, this project potentially increased awareness of TEG among healthcare providers,
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which can improve patient surgical outcomes. Also, this is valuable for the healthcare
organization because it promotes evidence-based practice. Research confirms that patient
outcomes improve when clinicians practice in an evidence-based manner. Additionally,
unnecessary blood products transfusion and complications can be reduced, while diminishing
healthcare costs, and improving blood product shortage.

Conclusion
Surgical bleeding is a medical risk impacting individuals undergoing anesthesia, and the
anesthesia provider must understand the appropriate management. As the number of individuals
with complex medical conditions undergoing anesthesia continues to increase, it is prudent for
measures to utilize TEG as a tool to direct blood product transfusion therapy. Presently, TEG is
not the standard of care for blood transfusion protocols in clinical practice. TEG This quality
improvement project has demonstrated that educational interventions can increase provider
knowledge of TEG and improve their likelihood of using this effective tool for surgeries and
patients at high risk for bleeding.
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Appendix A
Institution Approval letter

Envision
PHYSICIAN SERVICES
February l , 2022
Charles Buscemi, PhD, APRN
Clinical Associate Professor,
Florida International University
Dr. Buscemi,
Thank you for inviting Memorial Regional Hospital to participate in the Doctor of Nursing
Practice (DNP) project conducted by Yanet Villa Milanes entitled "An education intervention
to improve the knowledge of TEG: A Quality Improvement Project" in the Nicole Wertheim
College of Nursing and Health Sciences, Department of Nurse Anesthetist Practice at Florida
International University. I have warranted him permission to conduct the project using our
providers.
Evidence-based practice's primary aim is to yield the best outcomes for patients by selecting
interventions supported by the evidence. This project intends to evaluate if an educational
intervention to improves the knowledge of TEG.
We understand that participation in the study is voluntary and carries no overt risk. All
Anesthesiology providers are free to participate or withdraw from the study at any time. The
educational intervention will be conveyed by a 15-minute virtual PowerPoint presentation,
with a pretest and posttest questionnaire delivered by a URL link electronically via Qualtrics,
an online survey product. Responses to pretest and posttest surveys are not linked to any
participant. The collected information is reported as an aggregate, and there is no monetary
compensation for participation. All collected material will be kept confidential, stored in a
password-encrypted digital cloud, and only be accessible to the investigators of this study:
Yanet Villa Milanes and Dr. Buscemi We expect that Yanet Villa Milanes will not interfere
with normal hospital performance, behave in a professional manner and follow standards of
care.
Prior to the implementation of this educational project, the Florida International University
Institutional Review Board will evaluate and approve the procedures to conduct this project.
Once the Institutional Review Board's approval is achieved, this scholarly project's execution
will occur over two weeks. We support the participation of our Anesthesiology providers in
this project and look forward to working with you.
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Suzanne Hale, MSN, CRNA, ARNP
Advanced Practice Provider Director, Broward and Dade
Chief, Memorial Regional Hospital
Envision Physician Services
954-265-2044

3501 Johnson Street I Hollywood, FL 33021
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Appendix B
IRB approval letter

Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To:

Dr. Charles Buscemi

CC:

Yanet Milanes Villa

From:

Elizabeth Juhasz, Ph.D., IRB Coordinator

Date:

March 28, 2022

Protocol Title:

"Improve clinicians' knowledge of thromboelastography. A quality
improvement project"

The Florida International University Office of Research Integrity has reviewed your research
study for the use of human subjects and deemed it Exempt via the Exempt Review process.
IRB Protocol Exemption #:
TOPAZ Reference #:

IRB-22-0118
111514

IRB Exemption Date:

As a requirement of IRB Exemption you are required to:

03/28/22
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1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved prior to implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects, and/or
deviations from the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished or
discontinued.
Special Conditions:

N/A

For further information, you may visit the IRB website at http://research.fiu.edu/irb.
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Appendix C
Survey pre- and post-questions
1: When R parameter is prolonged?
A. administration of platelets is needed
B. administration of blood is necessary
C. administration of FFP is needed
D. administration of cryoprecipitate
2: A prolongation in clotting time (K) would indicate?
A: need for fibrinogen
B: need for cryoprecipitate
C: need RBC
D: need for cryoprecipitate
3: A decreased in maximum amplitude necessitate the administration of which blood product?
A: Albumin
B: Platelet
C: RBC
D: FFP
4: An increase in LY30 indicates?
A: it is normal values
B: coagulation factors are normal
C: indicates rapid fibrinolysis which will warrant an antifibrinolytic agent such as TXA
D: Indicate hemolytic anemia
5 : TEG has been proven to decrease unnecessary blood product transfusion after cardiac surgery
true or false?
6: Unnecessary blood product transfusion can lead to?
A: Stroke, infections, and TRALI
B: blood product transfusion is benign
C: increased WBC, hyperkalemia, hyponatremia
D: Increase sensitivity reactions.
7: In patients with cirrhosis, TEG is superior to international normalized ratio (INR) or platelet
count to estimate the risk for bleeding, true or false?
8: Obstetric hemorrhage can lead to:
A: deficiency of clotting factors
B: thrombocytopenia
C: hyperkalemia
D: hypervolemia
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9: Patients with end-stage liver disease who received transfusion therapy
A: Transfusion related acute lung
B: Hepatitis C
C: Acute hemolytic anemia
D: Red man syndrome
10: True or false TEG can assist clinicians in detecting coagulation deficiencies in obstetric
hemorrhage to determine the specific blood product therapy needed at an earlier point compared
with traditional laboratory testing?
11: TEG-guided transfusion protocol has shown to improve patient survival rates in trauma true
or false?

